Gentian Diagnostics
Mindre end 1K følgere
GENT
Oslo Børs
Medical Equipment & Services
Health Care
Oversigt
Investorkonsensus
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analyzers. Gentian's expertise and focus lies in homogeneous immunoassays, specifically infections, inflammation, renal failure and congestive heart failure. The company's headquarters and production facilities are located in Moss, Norway, and serves the global human and veterinary diagnostics market through sales and representative offices in a number of key countries.
Læs mereMarkedsværdi
-
Aktieomsætning
-
Omsætning
176,5 mio.
EBIT %
14,42 %
P/E
-
Udbytteafkast, %
-
Finanskalender
5.5
2026
Generalforsamling '26
6.5
2026
Delårsrapport Q1'26
6.5
2026
Årligt udbytte
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Gentian Diagnostics: Annual report 2025
Gentian Diagnostics ASA - Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program
Bliv en del af Inderes community
Gå ikke glip af noget - opret en konto og få alle de mulige fordele
Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer